Kotak Multi Asset Allocation Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

Kotak Multi Asset Allocation Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

Kotak Multi Asset Allocation Fund - Direct (G)

17.68%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

Deutsche Bank, AG Standard Chartered Bank

Computer Age Management Services (P) Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

100

14308.51

-

16.25

August 31, 2023

-

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

-

-

17.68 %

14.01 %

19.35 %

7.4 %

Devender Singhal

B.A. (Maths) from Delhi University and PGDM, Finance from Fore School of Management, Delhi.

Prior to joining Kotak Mahindra AMC, he has worked with kotak Securities Ltd.(July 2007 - January 2009) ,Religare (Feb 2006 - June 2007), Karvy (July 2004 - January 2006), P N Vijay Financial Services Pvt Ltd(2001- 2004) and Dundee Mutual Fund(Summer Trainee) (May 2000 - June 2000).

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right